RT Journal Article
SR Electronic
T1 PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006833
DO 10.1136/jitc-2023-006833
VO 11
IS 6
A1 Lo Russo, Giuseppe
A1 Prelaj, Arsela
A1 Dolezal, James
A1 Beninato, Teresa
A1 Agnelli, Luca
A1 Triulzi, Tiziana
A1 Fabbri, Alessandra
A1 Lorenzini, Daniele
A1 Ferrara, Roberto
A1 Brambilla, Marta
A1 Occhipinti, Mario
A1 Mazzeo, Laura
A1 Provenzano, Leonardo
A1 Spagnoletti, Andrea
A1 Viscardi, Giuseppe
A1 Sgambelluri, Francesco
A1 Brich, Silvia
A1 Miskovic, Vanja
A1 Pedrocchi, Alessandra Laura Giulia
A1 Trovo', Francesco
A1 Manglaviti, Sara
A1 Giani, Claudia
A1 Ambrosini, Paolo
A1 Leporati, Rita
A1 Franza, Andrea
A1 McCulloch, John
A1 Torelli, Tommaso
A1 Anichini, Andrea
A1 Mortarini, Roberta
A1 Trinchieri, Giorgio
A1 Pruneri, Giancarlo
A1 Torri, Valter
A1 De Braud, Filippo
A1 Proto, Claudia
A1 Ganzinelli, Monica
A1 Garassino, Marina Chiara
YR 2023
UL http://jitc.bmj.com/content/11/6/e006833.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.